Cytokinetics Inc. buy B. Riley
Start price
10.11.25
/
50%
€53.50
Target price
10.11.26
€77.87
Performance (%)
-4.60%
Price
29.04.26
€51.04
Summary
This prediction is currently active. With a performance of -4.60%, the BUY prediction by B__Riley is trending in the wrong direction. This prediction currently runs until 10.11.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -9.887% | -9.887% |
| iShares Core DAX® | -1.499% | 7.705% |
| iShares Nasdaq 100 | 1.380% | 16.275% |
| iShares Nikkei 225® | -1.992% | 13.113% |
| iShares S&P 500 | 0.345% | 10.816% |
Comments by B__Riley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by B__Riley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.00
22.09.25
22.09.25
€68.18
22.09.26
22.09.26
24.49%
29.04.26
29.04.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.60
04.06.24
04.06.24
€84.53
04.06.25
04.06.25
-35.43%
05.06.25
05.06.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.40
07.11.23
07.11.23
€61.81
07.11.24
07.11.24
61.68%
08.11.24
08.11.24